These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33308138)

  • 1. Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects.
    Saini AK; Saini R; Singh S
    Mol Med; 2020 Dec; 26(1):128. PubMed ID: 33308138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
    Wilk EJ; Howton TC; Fisher JL; Oza VH; Brownlee RT; McPherson KC; Cleary HL; Yoder BK; George JF; Mrug M; Lasseigne BN
    Mol Med; 2023 May; 29(1):67. PubMed ID: 37217845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease].
    Noël N; Rieu P
    Nephrol Ther; 2015 Jul; 11(4):213-25. PubMed ID: 26113401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
    Sessa A; Ghiggeri GM; Turco AE
    J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant.
    Muto S; Aiba A; Saito Y; Nakao K; Nakamura K; Tomita K; Kitamura T; Kurabayashi M; Nagai R; Higashihara E; Harris PC; Katsuki M; Horie S
    Hum Mol Genet; 2002 Jul; 11(15):1731-42. PubMed ID: 12095915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions.
    Malekshahabi T; Khoshdel Rad N; Serra AL; Moghadasali R
    J Cell Physiol; 2019 Aug; 234(8):12451-12470. PubMed ID: 30644092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
    de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
    Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on.
    Cornec-Le Gall E; Audrézet MP; Le Meur Y; Chen JM; Férec C
    Hum Mutat; 2014 Dec; 35(12):1393-406. PubMed ID: 25263802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy?
    Ponticelli C; Moroni G; Reggiani F
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic advances in ADPKD: the future awaits.
    Capuano I; Buonanno P; Riccio E; Amicone M; Pisani A
    J Nephrol; 2022 Mar; 35(2):397-415. PubMed ID: 34009558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cyst growth is attenuated by a combination treatment of tolvaptan and pioglitazone, while pioglitazone treatment alone is not effective.
    Kanhai AA; Bange H; Verburg L; Dijkstra KL; Price LS; Peters DJM; Leonhard WN
    Sci Rep; 2020 Feb; 10(1):1672. PubMed ID: 32015419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
    Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
    Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant polycystin-2 induces proliferation in primary rat tubular epithelial cells in a STAT-1/p21-independent fashion accompanied instead by alterations in expression of p57KIP2 and Cdk2.
    Felekkis KN; Koupepidou P; Kastanos E; Witzgall R; Bai CX; Li L; Tsiokas L; Gretz N; Deltas C
    BMC Nephrol; 2008 Aug; 9():10. PubMed ID: 18721488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells.
    Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G
    Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment.
    Reiterová J; Tesař V
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model.
    Bennett H; McEwan P; Hamilton K; O'Reilly K
    BMC Nephrol; 2019 Apr; 20(1):136. PubMed ID: 31014270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
    Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
    J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Manifestation and Management of ADPKD in Western Countries.
    Sommerer C; Zeier M
    Kidney Dis (Basel); 2016 Oct; 2(3):120-127. PubMed ID: 27921039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Autonomous Hedgehog Signaling Is Not Required for Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ma M; Legué E; Tian X; Somlo S; Liem KF
    J Am Soc Nephrol; 2019 Nov; 30(11):2103-2111. PubMed ID: 31451534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
    Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.